Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC
Qing Zhou, Ross A. Soo, Gee Chen Chang, Chao Hua Chiu, Hidetoshi Hayashi, Sang We Kim, Shunsuke Teraoka, Yasushi Goto, Jianying Zhou, Victor Ho-Fun Lee, Dong Wan Kim, Baohui Han, James Chung Man Ho, Chia Chi Lin, Shun Lu, Anna Polli, Anna Maria Calella, Jean François Martini, Chew Hooi Wong, Tony MokHye Ryun Kim, Yi Long Wu
Dive into the research topics of 'Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC'. Together they form a unique fingerprint.